A new computational method and gene-expression biology work converged on blood-based stratification, with evidence pointing to measurable diagnostic potential across cancer categories. One highlighted advance is a multi-omics approach that used a transformer framework to detect colorectal cancer signals, while other model-driven efforts continue to move biomarkers closer to clinical decision support. Separately, oncologists and radiology teams are testing AI and biomarker pipelines that can reduce time-to-measurement and improve consistency across imaging-derived endpoints. Together, these developments show a push toward scalable, blood-and-imaging-based workflows that can be deployed outside highly specialized centers. As these tools mature, the industry will focus on validation across sites, robustness to pre-analytical variation, and whether performance holds in prospective screening or response-monitoring settings.